RNS Number : 6688X

Omega Diagnostics Group PLC

31 August 2022


("Omega" or the "Company" or the "Group")

Change of preliminary results date

Omega (AIM: ODX), the specialist medical diagnostics company focused on industry-leading Health & Nutrition products, announces that the publication of the preliminary results for the year ended 31 March 2022 will be further delayed as the Company and its auditors require additional time to finalise the accounting treatment and disclosures relating to the recent sale of the CD4 business and for the Company's auditors to complete their transactional testing. This work is now expected to be completed in mid-September.

The delay to publication now means that the AGM planned for 5 October 2022 will no longer take place and a revised date will be communicated shortly.


  Omega Diagnostics Group PLC                                        www.omegadx.com 
  Jag Grewal, Chief Executive Officer                                via Walbrook PR 
  Chris Lea, Chief Financial Officer 
  finnCap Ltd                                                     Tel: 020 7220 0500 
  Geoff Nash/Edward Whiley/George Dollemore 
   (Corporate Finance) 
  Alice Lane/ Harriet Ward (ECM) 
  Walbrook PR Limited                     Tel: 020 7933 8780 or omega@walbrookpr.com 
  Lianne Applegarth                                               Mob: 07584 391 303 
  Sam Allen                                                       Mob: 07502 558 258 

About Omega Diagnostics Group PLC

Omega manufactures and distributes high quality in-vitro diagnostic products for use in hospitals, clinics, laboratories and healthcare practitioners in over 70 countries and is now focused on the health and nutrition sector.


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.



(END) Dow Jones Newswires

August 31, 2022 02:01 ET (06:01 GMT)

Omega Diagnostics (LSE:ODX)
Historical Stock Chart
From Feb 2023 to Mar 2023 Click Here for more Omega Diagnostics Charts.
Omega Diagnostics (LSE:ODX)
Historical Stock Chart
From Mar 2022 to Mar 2023 Click Here for more Omega Diagnostics Charts.